Protea Biosciences Concludes New Technology License Agreement
ProteaBio Europe SAS announced that the company has concluded an exclusive, worldwide license agreement with George Washington University for commercial rights to a new technology that provides rapid identification of a broad range of chemicals and biomolecules. Known as Laser Ablation Ele ... more
